Join Sameer Lal and Nikesh Shah as they explore how GenAI can revolutionize AE detection and classification, offering a game-changing solution by analyzing vast amounts of data from diverse sources. Discover how this advanced technology accelerates the AE reporting process, enhances signal detection, and facilitates proactive risk management. With significant efficiency, accuracy, and compliance improvements, GenAI is setting a new standard in pharmacovigilance practices.